ProfileGDS5678 / 1422344_s_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 18% 18% 18% 18% 20% 18% 17% 17% 18% 18% 41% 18% 18% 18% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.4579618
GSM967853U87-EV human glioblastoma xenograft - Control 22.4404718
GSM967854U87-EV human glioblastoma xenograft - Control 32.4449418
GSM967855U87-EV human glioblastoma xenograft - Control 42.3896118
GSM967856U87-EV human glioblastoma xenograft - Control 52.425320
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.4929118
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.4453717
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.4048617
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.410118
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.4290118
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.9508841
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.4119318
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.432618
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.4341318